Quantitative Systematic Strategies LLC Neurocrine Biosciences Inc Transaction History

Quantitative Systematic Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$96.16 - $135.15 $246,842 - $346,930	-2,567 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$85.09 - $130.36 $218,426 - $334,634	2,567 New	2,567 $313,000
Q4 2019 Feb 11, 2020	SELL	$86.8 - $118.57 $407,873 - $557,160	-4,699 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$83.82 - $101.5 $172,417 - $208,785	2,057 Added 77.86%	4,699 $423,000
Q2 2019 Jul 25, 2019	BUY	$72.24 - $91.27 $190,858 - $241,135	2,642 New	2,642 $223,000
Q4 2017 Feb 01, 2018	SELL	$58.53 - $77.59 $291,654 - $386,630	-4,983 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$47.97 - $61.28 $239,034 - $305,358	4,983	4,983 $305,000

655

95.2M

282K

281K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.